首页> 外文期刊>Canadian journal of surgery: Journal canadien de chirurgie >Heparin prophylaxis for deep venous thrombosis in a patient with multiple injuries: an evidence-based approach to a clinical problem.
【24h】

Heparin prophylaxis for deep venous thrombosis in a patient with multiple injuries: an evidence-based approach to a clinical problem.

机译:肝素预防多发伤患者的深静脉血栓形成:一种基于证据的临床问题方法。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To demonstrate a clinical decision-making process by which to determine if heparin prophylaxis for deep venous thrombosis (DVT) is appropriate in a specific patient with multiple injuries. DATA SOURCES: A Medline search of the literature. Search terms included trauma, heparin, deep venous thrombosis, thrombophlebitis, phlebitis, and trauma. STUDY SELECTION: Eleven studies were selected from 789 publications using published criteria. Incidence, risk and potential for prophylaxis were established through a structured review process. DATA EXTRACTION: After the structured review, a small number of studies were available for the consideration of incidence (2), natural history (4) and prophylactic therapy (2). DATA SYNTHESIS: The incidence of DVT in a patient with such multiple injuries is significant (58%-63%). The resulting risk of pulmonary embolism was 4.3% with an associated 20% death rate. Prophylaxis with low molecular weight heparin is associated with a statistically and clinically significant risk reduction for DVT when compared with unfractionated heparin and untreated controls. CONCLUSIONS: Few of the multiple available studies concerning trauma, DVT and pulmonary embolism meet reasonable standards to establish clinical validity. Available guidelines for literature evaluation allow surgeons to select relevant articles for consideration. Patients with multiple trauma appear to be at significant risk for DVT. The death rate associated with subsequent pulmonary embolism is significant. There is reasonably good evidence to suggest that low molecular weight heparin will reduce this likelihood without a significant risk of treatment complications.
机译:目的:证明临床决策过程,通过该过程可确定对多发伤的特定患者进行预防深静脉血栓形成(DVT)的肝素是否合适。数据来源:Medline文献检索。搜索词包括创伤,肝素,深静脉血栓形成,血栓性静脉炎,静脉炎和创伤。研究选择:使用公开的标准从789个出版物中选择了11项研究。通过结构化的审查过程确定了发生率,风险和预防潜力。数据提取:在进行结构化审查后,可以进行少量研究以考虑发病率(2),自然史(4)和预防性治疗(2)。数据综合:DVT在这种多发伤患者中的发生率很高(58%-63%)。肺栓塞的最终风险为4.3%,死亡率为20%。与普通肝素和未经治疗的对照组相比,低分子量肝素的预防与DVT的统计学和临床​​显着风险降低相关。结论:关于创伤,DVT和肺栓塞的多项可用研究中,很少有达到临床标准的合理标准。现有的文献评估指南允许外科医生选择相关的文章进行考虑。多发性创伤患者似乎有深静脉血栓形成的显着风险。与随后的肺栓塞相关的死亡率很高。有相当充分的证据表明,低分子量肝素可降低这种可能性,而不会显着增加治疗并发症的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号